We investigated whether combination treatment with a calcineurin inhibitor (tacrolimus) and IL-2 can selectively induce Treg expansion while inhibiting Tfh expansion, exerting an additive treatment effect against lupus nephritis-like symptoms. The gene discussed is IL2; the disease is lupus nephritis.